7-141973273-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_176817.5(TAS2R38):āc.417G>Cā(p.Lys139Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176817.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAS2R38 | NM_176817.5 | c.417G>C | p.Lys139Asn | missense_variant | 1/1 | ENST00000547270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAS2R38 | ENST00000547270.1 | c.417G>C | p.Lys139Asn | missense_variant | 1/1 | NM_176817.5 | P1 | ||
MGAM | ENST00000465654.5 | c.-3+27276C>G | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152092Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 249966Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135060
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461694Hom.: 0 Cov.: 62 AF XY: 0.0000220 AC XY: 16AN XY: 727134
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.417G>C (p.K139N) alteration is located in exon 1 (coding exon 1) of the TAS2R38 gene. This alteration results from a G to C substitution at nucleotide position 417, causing the lysine (K) at amino acid position 139 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at